Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib

Joint Bone Spine. 2023 Jul;90(4):105532. doi: 10.1016/j.jbspin.2023.105532. Epub 2023 Jan 25.
No abstract available

Keywords: Anti-NXP2; Calcinosis; Dermatomyositis; Interferon signature; JAK inhibitors.

Publication types

  • Letter

MeSH terms

  • Autoantibodies
  • Calcinosis* / complications
  • Calcinosis* / diagnostic imaging
  • Calcinosis* / drug therapy
  • Dermatomyositis* / complications
  • Dermatomyositis* / drug therapy
  • Humans
  • Interferons
  • Piperidines / therapeutic use

Substances

  • tofacitinib
  • Interferons
  • Piperidines
  • Autoantibodies